ATXS vs TSN · rev $706.0K vs P/E 22, rev $54.44B
Astria Therapeutics Inc (ATXS) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Tyson Foods Inc (TSN) is a farm products company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
ATXS currently screens at market cap $382.1M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the ATXS and TSN stock pages for the full models.
Not investment advice.